Denali Therapeutics Inc at Morgan Stanley Healthcare Conference Transcript
So great. So thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Pleased to have Denali with us.
Just quickly before we get going, I need to read an important disclosure statement. Please note that all important disclosures including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures. Or you can pick up your very own copy at the registration desk.
Questions & Answers
So I'm very pleased to have Alex Schuth with us. And Alex, I thought -- look, to start off, there've been a handful of neurology neurodegeneration companies that have come to market in the last 2 or 3 years. I thought maybe just it would be helpful to highlight what's your approach and why you think that approach is unique?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |